Literature DB >> 2080984

Isolation and characterization of NK cell or NK/T cell-specific cDNA clones.

J P Houchins1, T Yabe, C McSherry, N Miyokawa, F H Bach.   

Abstract

Natural killer (NK) cells are cytotoxic lymphocytes that share numerous cell surface antigens and functional components with T cells. However, in comparison with our knowledge of T cells, little is known about the molecular mechanisms of NK cell activation and function. The following study was initiated as an effort to obtain further information about similarities and differences between NK and T cells at the level of gene expression and also to identify NK-specific cDNA clones for future functional studies of the corresponding gene products. The study used cDNA libraries prepared from an NK clone and from an Epstein-Barr virus transformed B cell lymphoblastoid cell line (LCL). We employed a combination of differential and subtractive hybridization methodologies, which can successfully identify cell-specific cDNA clones representing medium to high abundance transcripts, to identify genes that are expressed in NK cells but not in the LCL. We were particularly interested to ascertain to what extent genes isolated in this manner would be expressed only in NK cells as opposed to being expressed in NK and T cells. Twelve different cross-hybridizing groups were identified that were not expressed in the LCL, and these groups were further characterized: (1) they were used to probe Northern blots prepared from a panel of cells including NK cells, T cells, and B cells: (2) changes in the steady-state level of message following T cell growth factor (TCGF)-induced activation of an NK cell clone were examined for selected isolates; and (3) a partial DNA sequence was determined for each cross-hybridizing group. The DNA sequences of seven groups were identical to previously reported sequences. One group was highly homologous with but not identical to what has been reported as a T cell specific gene, named 519. The DNA sequences of four groups showed no significant homology with the sequences in the GenBank and EMBL databases. The mRNA expression of the newly-identified groups demonstrated several different regulation patterns with respect to cell distribution and level of expression in response to TCGF-activation. Expression of the twelve different genes was examined in three populations of NK cells all of which were CD3- and possessed NK activity. Although these cells differentially expressed the prototype NK markers CD16 and CD56 (the cells were CD16+, CD56-, CD16-, CD56+ and CD16+, CD56+), the expression of all groups of cDNA clones was comparable in the three different types of NK cells despite the phenotypic differences.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2080984

Source DB:  PubMed          Journal:  J Mol Cell Immunol        ISSN: 0724-6803


  13 in total

1.  Genomic structure, chromosome location, and alternative splicing of the human NKG2A gene.

Authors:  B Plougastel; T Jones; J Trowsdale
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  Genomic structure of NKG5, a human NK and T cell-specific activation gene.

Authors:  J P Houchins; F Kricek; C S Chujor; C P Heise; T Yabe; C McSherry; F H Bach
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  A new approach to understanding T cell development: the isolation and characterization of immature CD4-, CD8-, CD3- T cell cDNAs by subtraction cloning.

Authors:  S L Orr; E Gese; L Hood
Journal:  Mol Biol Cell       Date:  1992-07       Impact factor: 4.138

4.  Variation in the ligand binding domains of the CD94/NKG2 family of receptors in the squirrel monkey.

Authors:  Michelle L LaBonte; Joanne Russo; Stephanie Freitas; Dawn Keighley
Journal:  Immunogenetics       Date:  2007-09-25       Impact factor: 2.846

5.  A multigene family on human chromosome 12 encodes natural killer-cell lectins.

Authors:  T Yabe; C McSherry; F H Bach; P Fisch; R P Schall; P M Sondel; J P Houchins
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Serum granulysin is a marker for Th1 type immunity in pre-eclampsia.

Authors:  M Sakai; K Ogawa; A Shiozaki; S Yoneda; Y Sasaki; K Nagata; S Saito
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 7.  Myelodysplastic syndrome and immunotherapy novel to next in-line treatments.

Authors:  Katherine Linder; Premal Lulla
Journal:  Hum Vaccin Immunother       Date:  2021-05-03       Impact factor: 3.452

8.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

9.  NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor.

Authors:  A G Brooks; P E Posch; C J Scorzelli; F Borrego; J E Coligan
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

10.  Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes.

Authors:  Sonja Latinovic-Golic; Michael Walch; Hanna Sundstrom; Claudia Dumrese; Peter Groscurth; Urs Ziegler
Journal:  BMC Immunol       Date:  2007-06-27       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.